Fusion Genomics Launches to Offer NGS-based Assay Development, Sarcoma Testing | GenomeWeb

NEW YORK (GenomeWeb News) – A new company named Fusion Genomics will offer next-generation sequencing-based assay development and bioinformatics services, Genome British Columbia said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.